AIG 2013 Annual Report Download - page 315

We are unable to develop a reasonable estimate of the maximum potential payout under certain of these
arrangements. Overall, we believe that it is unlikely we will have to make any material payments related to completed
sales under these arrangements, and no material liabilities related to these arrangements have been recorded in the
Consolidated Balance Sheets. See Note 4 herein for additional information on sales of businesses and asset
dispositions.
Pursuant to the terms of the ALICO stock purchase agreement, we agreed to provide MetLife with certain
indemnities. The most significant remaining indemnities include indemnifications related to specific product,
investment, litigation and other matters that are excluded from the general representations and warranties indemnity.
These indemnifications provide for various deductible amounts, which in certain cases are zero, and maximum
exposures, which in certain cases are unlimited, and may extend for various periods after the completion of the sale.
In connection with the indemnity obligations described above, approximately $19 million of proceeds from the sale of
ALICO remained in escrow as of December 31, 2013.
• See Note 10 for commitments and guarantees associated with VIEs.
• See Note 11 for disclosures about derivatives.
• See Note 26 for additional disclosures about guarantees of outstanding debt.
The following table presents a rollforward of outstanding shares:
Shares, beginning of year 400,000 300,000 100,000 – 147,124,067 (6,660,908) 140,463,159
Issuances – – – 20,000 100,799,653 – 100,799,653
Settlement of equity unit
stock purchase contracts – – – – 3,606,417 – 3,606,417
Shares exchanged (400,000) (300,000) (100,000) – 1,655,037,962 (11,678) 1,655,026,284
Shares purchased – – – – – (3,074,031) (3,074,031)
Shares cancelled – – – (20,000) – – –
Shares, end of year – – – – 1,906,568,099 (9,746,617) 1,896,821,482
Shares, beginning of year 1,906,568,099 (9,746,617) 1,896,821,482
Issuances 43,581 685,727 729,308
Shares purchased – (421,228,855) (421,228,855)
Shares, end of year 1,906,611,680 (430,289,745) 1,476,321,935
Shares, beginning of year
Shares issued
Shares repurchased
Shares, end of year
ALICO Sale
Other
16. EQUITY
Shares Outstanding
..................................................................................................................................................................................................................................
AIG 2013 Form 10-K 297
ITEM 8 / NOTE 15. CONTINGENCIES, COMMITMENTS AND GUARANTEES
Preferred Stock Common Treasury Common Stock
AIG Series E AIG Series F AIG Series C AIG Series G Stock Issued Stock Outstanding
Year Ended December 31,
2011
Year Ended December 31,
2012
Year Ended December 31,
2013
1,906,611,680 (430,289,745) 1,476,321,935
34,009 24,778 58,787
– (12,317,399) (12,317,399)
1,906,645,689 (442,582,366) 1,464,063,323
..................................................................................................................................................................................
............................................................................................................................................................................................
............................................................................................................................................................................................
............................................................................................................................................................................................
............................................................................................................................................................................................